Consensus ResMed, Inc.

Stocks

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - NYSE 23:00:02 30/10/2026 +03			5-day change	1st Jan Change
229.94 ^USD	-9.05%		-9.06%	-4.54%

10-30	RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating	MT
10-30	Citigroup Adjusts Price Target on ResMed to $270 From $240	MT

Evolution of the Average Target: ResMed, Inc.

Evolution of the Target Price: ResMed, Inc.

Changes in Analyst Recommendations: ResMed, Inc.

b15372734c4f3ff8093937.VVzvjrrgNOwmMvytYVwnVzqhJXb66cs9giAX8wXnVNM.ICTY3fGzV9xSZb3rJiRzAnDJbzOZg6RK7nNigHCrO5QXMaLA779mwV52tQ~f2028d308dda21288dbb999b6ce18228

Analysts' recommendations: ResMed, Inc.

10-30	RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating	MT
10-30	Citigroup Adjusts Price Target on ResMed to $270 From $240	MT
10-30	Wells Fargo Adjusts Price Target on ResMed to $250 From $215	MT
10-15	Baird Adjusts Price Target on ResMed to $238 From $213	MT
10-13	Mizuho Adjusts Price Target on ResMed to $240 From $235	MT
09-15	ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says	MT
09-15	RBC Upgrades ResMed to Outperform From Sector Perform, Raises Price Target to $262 From $244	MT
09-15	Analyst recommendations: Abercrombie & Fitch, Eli Lilly, Philip Morris, Ulta Beauty…
09-10	Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating	MT
09-03	Morgan Stanley Adjusts Price Target on ResMed to $225 From $227, Keeps Equalweight Rating	MT
08-31	KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating	MT
08-19	Rothschild & Co Redburn Initiates ResMed at Neutral With $230 Price Target	MT
08-07	Jefferies Adjusts Price Target on ResMed to $220 From $225	MT
08-07	Mizuho Adjusts Price Target on ResMed to $235 From $220	MT
08-07	Morgan Stanley Adjusts Price Target on ResMed to $227 From $229	MT
08-07	KeyBanc Capital Adjusts Price Target on ResMed to $255 From $260	MT
08-07	Piper Sandler Adjusts Price Target on ResMed to $225 From $233	MT
08-07	Baird Adjusts Price Target on ResMed to $213 From $217	MT
08-07	Wells Fargo Adjusts Price Target on ResMed to $215 From $225	MT
08-07	RBC Capital Adjusts PT on ResMed to $244 From $234, Maintains Sector Perform Rating	MT
08-07	Analyst recommendations: Micron Technology, Lockheed Martin, Airbnb, Johnson Controls International, The Allstate Corporation…
07-24	BofA Adjusts Price Target on ResMed to $320 From $310	MT
07-21	ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says	MT
07-17	RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276	MT
07-15	Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	RESMED, INC.					-0.52%
	THERMO FISHER SCIENTIFIC, INC.					+6.05%
	DANAHER CORPORATION					+9.67%
	INTUITIVE SURGICAL, INC.					+7.55%
	BOSTON SCIENTIFIC CORPORATION					+21.79%
	EDWARDS LIFESCIENCES CORPORATION					+7.86%
	SIEMENS HEALTHINEERS AG					+5.84%
	AGILENT TECHNOLOGIES, INC.					+0.5%
	VEEVA SYSTEMS INC.					-2.97%
	WATERS CORPORATION					-2.96%
	Average					+5.28%
	Weighted average by Cap.					+6.59%